Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy of an intra-operative, post-fixation fracture hematoma block compared to saline control on postoperative pain control in patients with acute femoral shaft fractures. Our primary outcome measure is visual analog scale (VAS) pain scores which are recorded at regular intervals.


Clinical Trial Description

This blinded, randomized control trial is being performed at the University of Cincinnati Medical Center. Patients will be randomly assigned to one of two treatment groups: Group One will be comprised of patients treated with fracture site injection containing 20 mL of 0.5% ropivacaine with an 18-gauge needle (150 mm length), Group Two will be comprised of patients treated with fracture site injection containing 20ml of normal saline. The injection will be administered by the orthopaedic trauma team after the insertion of the final intramedullary implant and skin closure prior to final surgical dressing application. The injection will be performed in a standard fashion with aspiration of hematoma followed by the injection. All postoperative management will be per standard of care. The size of the hematoma will have no effect on the procedure. When a hematoma block is utilized in the care of orthopaedic trauma patients, its aim is to infiltrate the anesthetic to the fracture edges and injured soft tissue to allow for pain control and fracture manipulation without additional sedation. Aspiration of the hematoma tells the clinician that the tip of the needle is near the fracture site and not in a neurovascular structure. The maximal single dose of ropivacaine without vasoconstrictor is 2-3 mg/kg.9 0.5% ropivacaine has 5 mg/mL of ropivacaine. 20 mL of 0.5% ropivacaine has 100 mg of ropivacaine. 100 mg of ropivacaine can be toxic to a patient less than 33-50 kg or 73-110 lb. If a patient weighs less than 110 lb, the ropivacaine dose will be scaled down below 2 mg/kg. Regional anesthesia including nerve blocks is not routinely used in the setting of traumatic femoral shaft fractures. A nerve block would compromise the patient's neurologic examination in the immediate postoperative period. Randomization will be performed via Microsoft Excel to generate random numbers. Allocation will be concealed and revealed to the surgical team in the hour prior to the procedure. The patients and the nursing staff who assess postoperative pain will be blinded to the treatment allocation. An a priori power analysis was performed to determine the sample size for the primary outcome measure. Prior literature has indicated that a difference of 1.3 on a VAS is clinically significant.5 Therefore, it was determined that a total of 44 patients were necessary per group to detect a 1.5-point difference on the VAS (power = 80%, p = 0.05). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04860856
Study type Interventional
Source University of Cincinnati
Contact Kimberly A Hasselfeld
Phone 5137776213
Email [email protected]
Status Recruiting
Phase Phase 4
Start date August 17, 2019
Completion date June 1, 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03231787 - Clinical Trial in Antiaggregated Patients With Proximal Femur Fracture Evaluating a Strategy to Shorten Time Until Surgery N/A
Not yet recruiting NCT03868280 - The FLiP Study, a Pilot Cluster Randomized Trial N/A
Completed NCT00888160 - Timing of Orthopaedic Surgery in the Multiply-injured Patient: Development of a Protocol for Early Appropriate Care
Withdrawn NCT00240396 - Bimodal Analgesia as Form of Pain Control Post Long Bone Fracture N/A
Recruiting NCT01969279 - Radiographic Influences of Bisphosphonate Treatment on Femur N/A
Active, not recruiting NCT03160508 - Trochanter Fixation Nail Advanced (TFNA) Weight Bearing
Completed NCT04127045 - ProspEctive Cohort Study on Multidisciplinary Approach to Femur FRactures' manAgement in Over 65 Population
Completed NCT00725894 - Pediatric Locking Nail for the Treatment of Femoral Fractures in Children N/A
Recruiting NCT04657510 - Femoral frACturEs and COVID-19.
Recruiting NCT03775408 - FAST: Clinical Feasibility
Completed NCT02793947 - Efficacy of Peri-Incisional Multimodal Drug Injection Following Operative Management of Femur Fractures Phase 4
Completed NCT00916136 - Skeletal Versus Cutaneous Traction For Treatment of Femur Fractures N/A
Not yet recruiting NCT00616044 - Continuous Spinal Anesthesia Versus Combined Spinal Epidural Block N/A
Terminated NCT01484405 - Anterolateral Versus Posterior Approach for Total Hip Arthroplasty After Displaced Femoral Neck Fracture N/A
Completed NCT00943332 - Pediatric Femur Research Project
Not yet recruiting NCT00686023 - Comparing Surgical Techniques for CRIF of Pertrochanteric Fractures N/A
Completed NCT01293916 - Spica Casting in Pediatric Femur Fractures: Study of Single Leg Versus Double Leg Spica Casts N/A
Completed NCT00593333 - Intramedullary Nailing of the Femur:Trochanteric vs Piriformis Starting Portals N/A
Completed NCT03117868 - Mortality of Patients Undergoing Fracture of the Upper Extremity u Femur at the University Hospital of Amiens
Recruiting NCT04306536 - Nutritional Support in Femur Fracture Rehabilitation N/A